Business Context and Reporting Period
Company: Bioaffinity Technologies, Inc. (BIAF)
Filing Type: Form 8-K (Current Report)
Date of Report: October 16, 2025
Reporting Period: Event-based report for October 16, 2025
Business Context: The registrant is an emerging growth company incorporated in Delaware, trading on the Nasdaq Capital Market. The filing reports a significant intellectual property milestone regarding its lung cancer detection technology.
Key Financial Metrics
This Form 8-K filing does not contain financial statements, revenue figures, profit data, cash flow information, margin analysis, debt levels, or liquidity metrics. The document is strictly an event notification.
Material Changes
Intellectual Property Milestone: On October 16, 2025, the company received a notification of allowance from the United States Patent and Trademark Office (USPTO) for a new patent.
Patent Title: "Detection of Early-Stage Lung Cancer in Sputum using Automated Flow Cytometry and Machine Learning."
Scope: The patent covers a system and method for predicting the likelihood of lung cancer by analyzing patient sputum samples.
Guidance, Outlook, and Risks
Management Commentary: The filing references a press release (Exhibit 99.1) announcing the patent allowance but does not include forward-looking guidance, financial outlook, or specific management commentary within the text of the 8-K itself.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text beyond the standard nature of patent applications and emerging growth company status.
Investor Verification Checklist
- Verify the full text of the press release attached as Exhibit 99.1 for detailed commercial implications of the patent.
- Confirm the status of the patent issuance and any associated maintenance fees or timelines for final grant.
- Review recent 10-K or 10-Q filings for the company's current cash position and runway, as this 8-K contains no financial data.
- Assess the competitive landscape for sputum-based lung cancer detection to evaluate the patent's market value.